Ixchel To 9th Circ. In Biogen Row: Companies Are People, Too
Ixchel Pharma LLC urged the Ninth Circuit at a hearing Wednesday to revive allegations that Biogen Inc. illegally undermined its development of a neuromuscular disease treatment by signing an anti-competitive deal...To view the full article, register now.
Already a subscriber? Click here to view full article